Loading clinical trials...

A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA) | Clinical Trials | Clareo Health

COMPLETED

A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)

Non-interventional Study to Assess the Arm Activity Measure Questionnaire (ArmA) by Patients With Adult Upper Limb (AUL) Spasticity.

NCT05546190•Ipsen

View on ClinicalTrials.gov

Summary

The participants of this study will have AUL spasticity and have a need for botulinum toxin type A injections. AUL spasticity is where people develop tightening or stiffness of the muscles in the arms. Botulinum toxin type A is used for the treatment of spasticity in addition to physiotherapy. This study will ask participants to describe their experience living with AUL spasticity. This information will be used to assess the Arm Activity Measure (ArmA). ArmA is a scale designed to assess upper limb function in people with AUL spasticity. This study could suggest changes to the ArmA to improve its suitability for people with AUL spasticity or even the development of a new scale.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Participant has provided informed consent and is willing to take part in the study
•Participant is an adult aged at least 18 years
•Participant has a clinical diagnosis of spastic hemiparesis following stroke or traumatic brain injury (TBI) affecting one arm only
•Participant is at least 6 months post-stroke or TBI
•Participant has a need for botulinum toxin type A injections as part of their treatment for AUL spasticity
•Patient is considered to be in a stable state with regard to their therapeutic interventions (i.e., all treatments for the patient's condition have been stable for at least one month prior to assessment of eligibility)
•Participant has access to the internet, laptop, or tablet, and is willing to take part in either an online focus group or interview (caregiver assistance is acceptable)
•Participant is fluent in the English language and is able to discuss their condition

Exclusion Criteria

•Participant has any medical condition that prohibits their ability to communicate with the interviewer including severe dysphasia or an inability to read questionnaires.
•Participant has any other clinically relevant concern (e.g., significant psychiatric disorder or depression, history of alcohol and/or drug abuse) that in your opinion would interfere with their ability to provide written informed consent and/or participate.
•Participant has AUL spasticity is present in both arms

Locations (2)

Rancho Los Amigos National Rehab

Downey, California, United States

MedStar National Rehabilitation Network

Washington D.C., District of Columbia, United States

Key Dates

Start Date

September 20, 2022

Primary Completion Date

March 23, 2023

Completion Date

March 23, 2023

Last Updated

April 18, 2023

Enrollment

ACTUAL participants

Conditions

Spastic HemiparesisMuscle Spasticity

Utility of CC7 Transfer in Stroke Subtypes

NCT06001736

Stroke, IschemicStroke Hemorrhagic+1 more

View study

RECRUITINGNA

Exoskeleton and Spinal Cord Stimulation for SCI

NCT03096197

Spinal Cord InjuryAmbulation Difficulty+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 18, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)

Inclusion Criteria

Exclusion Criteria

Utility of CC7 Transfer in Stroke Subtypes

Exoskeleton and Spinal Cord Stimulation for SCI

SIRS-ESWT Trial: Shoulder Internal Rotator Spasticity Trial Treated With Extracorporeal Shock Wave Therapy Trial

"Comparison of Therapist-Led and Robot-Assisted Arm Therapy in Subacute Stroke Rehabilitation"

Soleus Loading Response During Walking

Measurements of Displacement Amplitude and Angular Velocities During Passive Extension of the Wrist and Hand Complex in Stroke Patients